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Abstract
Background: In medical practice many, essentially continuous, clinical parameters tend to be categorised by
physicians for ease of decision-making. Indeed, categorisation is a common practice both in medical research and in
the development of clinical prediction rules, particularly where the ensuing models are to be applied in daily clinical
practice to support clinicians in the decision-making process. Since the number of categories into which a continuous
predictor must be categorised depends partly on the relationship between the predictor and the outcome, the need
for more than two categories must be borne in mind.
Methods: We propose a categorisation methodology for clinical-prediction models, using Generalised Additive
Models (GAMs) with P-spline smoothers to determine the relationship between the continuous predictor and the
outcome. The proposed method consists of creating at least one average-risk category along with high- and low-risk
categories based on the GAM smooth function. We applied this methodology to a prospective cohort of patients with
exacerbated chronic obstructive pulmonary disease. The predictors selected were respiratory rate and partial pressure
of carbon dioxide in the blood (PCO2), and the response variable was poor evolution. An additive logistic regression
model was used to show the relationship between the covariates and the dichotomous response variable. The
proposed categorisation was compared to the continuous predictor as the best option, using the AIC and AUC
evaluation parameters. The sample was divided into a derivation (60%) and validation (40%) samples. The first was
used to obtain the cut points while the second was used to validate the proposed methodology.
Results: The three-category proposal for the respiratory rate was ≤ 20;(20, 24];> 24, for which the following values
were obtained: AIC=314.5 and AUC=0.638. The respective values for the continuous predictor were AIC=317.1 and
AUC=0.634, with no statistically significant differences being found between the two AUCs (p = 0.079). The
four-category proposal for PCO2 was ≤ 43;(43, 52];(52, 65];> 65, for which the following values were obtained:
AIC=258.1 and AUC=0.81. No statistically significant differences were found between the AUC of the four-category
option and that of the continuous predictor, which yielded an AIC of 250.3 and an AUC of 0.825 (p = 0.115).
Conclusions: Our proposed method provides clinicians with the number and location of cut points for categorising
variables, and performs as successfully as the original continuous predictor when it comes to developing clinical
prediction rules.
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Background
Generally speaking, in medical practice it is quite com-
mon for physicians to take many clinical parameters that
are essentially continuous variables and categorise them
for practical reasons. Clinical practice tends to perceive
test results as either normal or abnormal, or as nor-
mal, uncertain or abnormal, or alternatively to use such
results as a severity scale of the patient’s prognosis for a
given outcome. In particular, this is the case in clinical
research where many continuous variables are categorised
on the basis of the normality/abnormality principle, dis-
ease severity (ordinal) or grouping (non-ordinal). This
practice reflects physicians’ way of thinking and their clin-
ical decision-making process, and so in a research context
categorisation is a common way [1] of rendering results
more useful and more practical.
More specifically, a field where categorisation is widely
used is that of clinical prediction rules (CPRs), which are
relevant for decision-making in medicine [2]. Many CPRs
are based on statistical models in which a number of clin-
ical variables are regarded as potential predictors. Where
the aim is to apply the model to routine clinical practice,
definitions of outcomes and predictors should be in line
with standard practice [2]. Furthermore, both the associa-
tion between the predictor and the response variable, and
the probability distribution of the predictor could deter-
mine the strength of the covariate in the model. Hence,
the final model’s performance and goodness-of-fit will
depend on the choice of a good and practical definition
of the variables, an adequate measure of the association
between predictor and outcome, and the strength of the
covariate in the model. It is well documented that, from a
purely statistical point of view, it is preferable to develop
a statistical model using continuous rather than categor-
ical covariates, since categorisation may lead to loss of
information and reduction in power [3,4]. From a practical
standpoint, however, continuous predictors are not often
considered in the development of CPRs [2,5,6]. There are
two main reasons for this: firstly, whenever a continuous
covariate is incorporated into a model, the assumption
of the linear relationship between the outcome and the
covariate should be tested, and this is often not acceptable.
Consequently, the statistical analysis itself could become
a methodological challenge. Secondly, categorisation is
like a mirror of clinical practice. Research results are
important in the development of clinical practice, where
decisions tend to be categorical in nature. Consequently,
models with categorical predictors could be more eas-
ily understood and applied to clinical decision-making by
clinicians. At times, decisions are based on clinical crite-
ria that take a continuous marker as baseline, and select
one or more cut points to determine whether or not a
given patient has a certain status or diagnosis. Such cri-
teria can vary enormously from one practitioner, hospital
or even country, to another (an illustration of this will
be given below); indeed, a meta-analysis conducted by
Lim and Kelly showed that reported cut-off values for
PCO2 (partial pressure of carbon dioxide in the blood) for
screening hypercapnia ranged from 30 to 46 mmHg [7].
The search for adequate categorisation of clinical contin-
uous variables is thus a relevant topic in the development
of CPRs.
Previous work has been done on the categorisation of
continuous variables. In a review of methods for cate-
gorising a predictor, the methods concerned were divided
into two groups [6]: a) exploratory plots; and, b) a min-
imum p-value approach. Insofar as exploratory plots are
concerned, Hin et al. proposed a method for dichotomis-
ing continuous variables using Generalised AdditiveMod-
els (GAMs) [8]. The number of categories into which
the continuous predictor should be categorised depends
partly on the relationship -graphical and numerical-
between the predictor and the outcome: hence, the need
to create more than two categories should be borne in
mind. This happens, for instance, with variables such as
blood pressure, where a single cut point cannot be used
to divide patients into high- and low-risk groups, since
patients with high and those with low values are both
associated with higher risk [9]. Furthermore, a very recent
work criticised the arbitrary and frequent use made of
quantiles in epidemiological research to categorise contin-
uous variables [10].
Recent literature is unanimous in making the point that
categorising continuous predictors should be well justi-
fied and motivated, and that, if necessary, the selected
criterion for categorisation should be objective and suffi-
ciently validated. The aim of this study was to propose a
criterion for categorising continuous variables to be used
in CPRs, by seeking both the optimal number of cat-
egories and the optimal cut points. The starting point
of our proposed method is to examine the association
between a continuous covariate and a pre-defined rele-
vant outcome, using GAMs. This will allow us, in turn,
to focus on the prediction of the chosen outcome, select
the pertinent cut points, and create as many categories
as required. The proposed method of categorisation con-
siders the functional relationship between the covariate
and the outcome, thereby ensuring that critical informa-
tion is not lost from the continuous variable. Moreover,
it is intended that the ensuing categorisation will be use-
ful from a practical point of view, by combining good
prediction ability with ease of use in routine clinical prac-
tice. The proposed method of categorisation was applied
to real data drawn from the IRYSS-COPD Study (IRYSS:
Red de investigación cooperativa para la Investigación en
Resultados de Salud y Servicios Sanitarios - Co-operative
Health Outcomes & Health Services Research Network),
and then validated by comparing it to other methods.
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The remainder of this paper is divided into three
sections. In the Methods section, the GAM theory
is briefly described and the proposed categorisation
methodology is explained in detail. In addition, this
section presents the IRYSS-COPD Study in which the pro-
posed methodology is to be tested and validated, with
a detailed outline of the methods used for validation
purposes. The Results section reports the results of the
application of the proposed methodology to real data as
well as the validation process. Finally, the paper ends with
a discussion and some conclusions.
Methods
The Methods section is divided into two subsections: the
first is devoted to the theoretical aspects of the method-
ology and includes a brief introduction to GAMs, in order
to render the proposed methodology more easily under-
standable; the second focuses on the methods for applying
the proposed methodology to real data and the criteria
selected for validating the proposal.
Theoretical methods
Generalised additivemodels
GAM [11] is an extension of the Generalised LinearModel
(GLM) where the modelling of the mean functions relaxes
the assumption of linearity, albeit additivity of the mean
function pertaining to the covariates are assumed. Whilst
the mean functions of some covariates may be assumed
to be linear, the non-linear mean functions are mod-
elled using smoothingmethods, such as kernel smoothers,
lowess, smoothing splines or regression splines. In gen-
eral, the model has the following structure




where μ = E(Y ) for Y, a response variable with some
exponential family distribution, g is the link function, and
fi are some smooth functions of the covariates Xi for each
i = 1, . . . , p.
GAMs provide more flexibility than do GLMs, as they
relax the hypothesis of linear dependence between the
covariates and the expected value of the response vari-
able. The main drawback of GAMs lies in the estimation
of the smooth functions fi, and there are different ways
to address this. One of the most common alternatives
is based on splines, which allow the GAM estimation to
be reduced to the GLM context [12]. Splines are piece-
wise polynomials that join at points called knots: two
major families belong to these models, i.e., regression
splines and smoothing splines. Regression splines con-
sist of selecting the number and location of the knots,
and imposing restrictions so that the piecewise polyno-
mials join smoothly. Smoothing splines [13], use as many
knots as unique values of the covariate Xi and control
the model’s smoothness by adding a penalty to the least-
squares fitting objective [14]. An intermediate alternative
to building the smooth functions -and one that considers
the advantages of both smoothing and regression splines-
is the use of penalised splines (also known as P-splines),
introduced by Eilers and Marx [15]. P-splines use fewer
knots than smoothing splines and introduce more gen-
eral roughness penalties which relaxes the importance of
the knot location. We have included a brief description of
splines here and more detailed theoretical information is
included in Appendix 1.
Categorisationmethodology
Our proposal consists of categorising continuous vari-
ables by using GAM models with P-spline smoothers.
Without loss of generality, let us assume that there is a
continuous variable X which we wish to categorise and
a response variable Y with some exponential family dis-
tribution. In such a case, the GAM model defined in (1)
is fitted with X as the covariate and Y as the response
variable.
g(μ) = α0 + f (X) (2)
where g is the link function and μ = E(Y ).
The aim of this method is to categorise the covariate X,
based on the influence it has on the response variable Y.
The number of categories as well as the location of the cut
points will depend on the graphical relationship obtained
by using the GAMmodel with P-spline smoothers. On the
basis of this model, the graphical display shows the rela-
tionship between X and f (X), where X is plotted on the
horizontal axis and the smooth function f is plotted on
the vertical axis. f (X) is the centeredmean function where
the centering coefficient is α0, this is f (X) = 0 refers
to the average value of the covariate.We therefore propose
to start by creating an average-risk category around this
average-risk point, together with as many high- and low-
risk categories as are required to capture the relationship
between X and f (X), as outlined in detail below.
We consider an average-risk category, by building an
interval around the point x0 ∈ X, such that f (x0) = 0.
To do so, we calculate the value for x0, by computing the
inverse of f, and then the estimated value μˆ0, such that:
μˆ0 = g−1(α0 + f (x0)) = g−1(α0)





ˆμ0inf = μˆ0 − 1.96se(μˆ0)
and
ˆμ0sup = μ0 + 1.96se(μˆ0)
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where se(μˆ0) is the estimated standard error of the
expected response given by the GAM evaluated at point
μˆ0.





the process, such that
f −1(g( ˆμ0inf ) − α0) = x0inf
and
f −1(g( ˆμ0sup) − α0) = x0sup
This is, the points x0inf and x0sup are thus the cut points
that determine the average-risk category. Therefore, the
interpretation of this average-risk category, is that for any
x ∈ (x0inf , x0sup) this point is considered an average-risk
point, the same as x0.
If x0 is not unique, i.e., if the graph displayed crosses
the vertical axis more than once at point 0, then there will
be more than one average-risk category, provided that the
band at x0, is not too wide (with the band being taken
to mean the confidence interval shown in the graph). In
other words, if x01 and x02 are two values for which the
graph crosses the vertical axis at point 0, two average-








do not overlap. If the last happens,
we hypothesise that it may be due to two situations. The
first is that one of the two intervals is based on a very
small sample size which leads to a non-accurate and hence
very wide interval. The second is the overlapping of two
intervals of similar size. Under the first circumstance, we
suggest to dismiss the interval based on a very small sam-
ple. However, if the second circumstance happens, we will
consider the union of both intervals as the average-risk
category.
Once the average-risk category has been defined, the
following two possible scenarios are considered in order
to create high- and low-risk categories:
1. The relationship shown on the graph between the
covariate and the outcome given by the GAM is
linear along the entire range of X. Under this
scenario, we propose to categorise X into a minimum
of three categories, with the cut points for the three
being selected as the limits of the average-risk
category. This hypothetical situation is depicted in
Figure 1(a). Moreover, if more categories are needed
to ensure that the linear relationship between the
covariate and the outcome is adequately retained,
these could be created by considering appropriate
cut points, preferably based on clinical criteria, in any
of the designated high-risk or low-risk categories; or,
2. The relationship shown on the graph between the
covariate and the outcome given by the GAM is not
linear, which means that there is either a jump or a
change in the slope. Firstly, we propose to proceed as
described above for the first three categories, labelled
"average-risk", "low-risk" and "high-risk". Secondly,
the points at which the slope change occurs will be
deemed to be extra cut points. Consequently, this
will lead to the corresponding low-risk or high-risk
categories, or both, being re-categorised as very low-
and low- or very high- and high-risk categories
respectively. The selection of these extra cut points
will be made on the basis of graphical visualisation of
the slope and the clinical significance of the cut point
in question. This hypothetical situation of one extra
cut point is depicted in Figure 1(b)
In both cases, the need for more than the proposed
minimum number of categories will be evaluated by com-
paring the results of adding more categories to the orig-
inal continuous covariate, using the validation criterion
explained in detail below.
Implementation methods
Application to the IRYSS-COPD study database
We applied the methodology proposed in this paper to
a prospective cohort of patients with chronic obstructive
pulmonary disease (COPD), including for study purposes
a sample of 2877 patients with exacerbated COPD attend-
ing the emergency departments (EDs) of 16 participating
hospitals in Spain. Information was recorded: at the date
on which patients were evaluated at the ED; at the date
on which the decision was made to admit patients or
discharge them home; and during follow-up after admis-
sion or discharge home. The main data collected were
those relating to patients’ respiratory function (e.g., arte-
rial blood gases, respiratory rate (RR), dyspnea) on arrival
at the ED and at the time of the decision to admit them
to ward or discharge them home (for fuller details see the
IRYSS-COPD Study [16]).
By way of an illustration of the application of the pro-
posed methodology, we selected part of the IRYSS-COPD
Study, specifically: one dichotomous outcome; poor evo-
lution in the first 7 days from arrival at the ED (which
includes any of the following: death, ICU admission, the
need for invasive mechanical ventilation, cardiac arrest,
non-invasive mechanical ventilation for more than 2
days when mechanical ventilation was not needed before
admission, and/or admission to an intermediate respira-
tory care unit for 2 or more days [16]); and two continuous
covariates, namely, the blood gas parameter, PCO2, and
the RR. Exacerbated COPD is a severe condition quite
commonly seen at EDs, where proper decision-making
tools are vitally important for performing the neces-
sary diagnoses and implementing the treatments that are
urgently required. Among the basic diagnosis tests used
for classifying the severity of presentation of exacerbated
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Figure 1 Graphical representation of two hypothetical shapes between the predictor and outcome using generalised additive models.
(a) Linear relationship (b) Non-linear relationship.
COPD in such patients, arterial blood gases are the main
tool. PCO2 is a highly valuable item of information drawn
from arterial blood gases; similarly, another key item of
information is proper assessment of patients’ respiratory
rate, something that is invariably affected in these cases.
Furthermore, these two variables represent the two possi-
ble theoretical scenarios described above.
Considering a dichotomous outcome Y, the link logit
was used in the GAM model. In such a case, the model
described in (2) for one covariate X would be more pre-
cisely specified by the following expression:
logit(p) = α0 + f (X) (3)
where p represents the probability of Y = 1, which is
interpreted as the probability of a patient having a poor
evolution.
Validation
The total sample was randomly divided into a deriva-
tion (60%) and validation (40%) sample. Cut points were
obtained using the derivation sample while validation
sample was used for method evaluation purposes.
The method for categorising continuous covariates was
evaluated, by comparing the performance of the proposed
categorical predictor in the model to that of the origi-
nal continuous variable modelled by a GAM as the best
option in the same model. In addition, we also compared
the proposed categorisation to the dichotomised variable
suggested by Hin et al. (1999) [8].
To compare models using different approaches to rep-
resent the same covariate, two criteria were selected: the
first was the Akaike Information Criterion (AIC), a well-
known, classical method for comparing two models [17];
the second method of evaluation was based on the spe-
cific model defined in equation (3) and the study’s des-
ignated purpose. In this particular case, we desired to
evaluate the prediction ability of the model selected. We
thus proposed to use the area under the receiver operat-
ing characteristic (ROC) curve (AUC) as the parameter
that quantifies a logistic model’s ability to predict. The
AUCs for two ROC curves were compared using the
DeLong test [18].
Additionally, the goodness-of-fit of the proposed cat-
egorisation was evaluated by means of the Hosmer-
Lemeshow test, which assesses the concordance between
observed and expected event rates in a logistic regression
model [19]. Finally, the need for additional categories, in
excess of a minimum of three, was also checked by test-
ing for statistically significant differences in risk between
additional and adjacent categories.
Finally, we performed a sensitivity analysis in order to
assess the impact sample size may have on the width of
the average-risk category. We recalculated the average-
risk category for PCO2 and for samples of size 200, 400,
600, 800, 1000 and 1200 obtained resampling without
replacement from the original sample.
All statistical analyses were performed using the R soft-
ware package. The mgcv, BB and pROC libraries were
specifically used to compute the GAM model, cut points
and AUC values respectively. The R code used to imple-
ment the proposed methodology in the application pre-
sented here is shown in Additional file 1.




RR: The relationship between the RR and poor evolu-
tion, as plotted by an additive logistic regression model
with smoothing P-splines, is depicted in Figure 2. It will
be seen that the relationship between the RR and poor
evolution was linear and that there was only one value
for which f (x0) = 0 (x0 = 22). Application of the pro-
posedmethodology to determine the limits of the average-
risk category showed this category to be (20-24). It was
therefore decided that the RR would be classified into 3
categories (Figure 2), with a high risk of poor evolution for
values above 24 and a low risk of poor evolution for those
below 20: accordingly, our final proposal for classifying the
RR into three categories was ≤ 20; (20,24]; >24.
In the search for an optimal fit to the original model, the
need for a fourth category was explored. Taking the num-
ber of individuals with an RR above 24 and the available
clinical information about the disease into consideration
[20], an additional cut point of 30 was selected. The fol-
lowing four-category RR version, namely, ≤ 20; (20,24];
(24,30]; >30, was thus also tested.
In addition, the RR variable was dichotomised as indi-
cated before, whereby an RR value for which there is an
average risk of poor evolution is taken as the cut point,
which in our case was 22: consequently, our dichotomous
RR proposal was ≤ 22; >22.
PCO2: The relationship between PCO2 and poor evo-
lution, as plotted by an additive logistic regression model
with smoothing P-splines, is shown in Figure 3. In this
case, the relationship did not prove linear, with a trend
towards a less steep slope for higher values. We started
by calculating an average-risk category: this was (43-52),
meaning that there was a high risk of poor evolution for
values above 52 and a low risk of poor evolution for those
below 43. The need to select more cut points was then
explored. From 40 to 43, the relationship was linear, and
below this there was no significance because the confi-
dence interval was too wide. Above 52, however, there
were several points where there was a slope change.While
all values above 80 were dismissed, since the confidence
interval was too wide and there were very few patients
with PCO2 values as high as this, graphical examination of
values below 80 nevertheless showed 65 to be a reasonable
cut point for distinguishing between the high- and very
high-risk categories. Finally, we decided on the 4-category
PCO2 proposal shown in Figure 3, namely, ≤43;(43-52];
(52-65]; >65.
As in the case of the RR above, the PCO2 variable
was also dichotomised, whereby a PCO2 value for which
there is an average risk of poor evolution is taken as
the cut point. Since the value in this particular instance
was 47, the dichotomous PCO2 proposal was therefore ≤
47; > 47.



















Figure 2 Graphical representation of the cut points obtained for the respiratory rate. Cut points obtained, based on the relationship between
respiratory rate and poor evolution.
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Figure 3 Graphical representation of the cut points obtained for PCO2. Cut points obtained, based on the relationship between PCO2 and
poor evolution.
Validation
We considered the assessment parameters, AIC and AUC,
obtained from the continuous predictor in a GAM as the
best option and those obtained with the dichotomised
option as perhaps needing improvement. Detailed results
of the validation process are shown in Table 1.
RR: Our approach proposed that the RR be classified
into a minimum of 3 categories, for which the follow-
ing values were obtained: AIC=314.5 and AUC=0.638 for
the 3-category option versus AIC=317.1 and AUC=0.634
for the continuous predictor, with no statistically sig-
nificant differences being found between the two AUCs
(p = 0.8198). The respective values for the dichotomous
predictor were AIC=318.1 and AUC=0.594. Statistically
significant differences in AUCs were observed between
the dichotomous and proposed 3-category approaches
(p = 0.049).
Lastly, the 4-category option yielded an AIC of 316.2
and an AUC of 0.64. No statistically significant dif-
ferences in AUCs were observed when this was com-
pared to both the continuous (p = 0.6833) and the
3-category approaches (p = 0.5968). Moreover, when
the model for the 4-category option was adjusted, how-
ever, non-statistical differences were found between the
estimated parameters for the (24,30] and >30 categories
(p = 0.074). Detailed results of the adjusted model are
shown in Table 2.
Additionally, the models for the 4-category and
3-category options were both well calibrated (Hosmer-
Lemeshow test p-values > 0.05 in both cases). Further-
more, when the proposed 3-category option was applied
to other outcomes, such as admission to ward, it was
able to detect differences between categories. When com-
pared to the average-risk category, the estimates of the
coefficients in a logistic model for the low- and high-
risk categories were −0.81 and 0.68 respectively (p-values
< 0.001 in both cases).
PCO2: Our approach proposed that the PCO2 variable
be classified into 4 categories, for which the following
values were obtained: AIC=258.1 and AUC=0.81 for the
4-category option versus AIC=250.26 and AUC=0.825
for the continuous predictor, with no statistically signif-
icant differences between the two AUCs (p = 0.1148).
The respective values for the dichotomous predictor were
AIC=281.5 and AUC=0.742. Statistically significant differ-
ences in AUCs were observed, not only between the con-
tinuous and dichotomous approaches (p < 0.0001), but
also between the dichotomous and proposed 4-category
approaches (p = 0.0001). In addition, we verified the need
to create a fourth category, by comparing the 4-category
against the 3-category predictor (our minimum proposal).
Statistically significant differences were found between
both AUCs (p = 0.0004), with the AUC value for the
3-category predictor being 0.779.
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Table 1 Categorisation of the respiratory rate (RR) and
PCO2 covariates from the IRYSS-COPD study, based on the
proposedmethodology
Derivation (N = 805) Validation (N = 545)
Variable Cut points AIC AUC p-value*
RR Continuous† 317.10 0.634 -
RR Dichotomised ≤ 22 318.10 0.594 0.079
> 22
RR 3-category ≤ 20 314.50 0.638 0.8198
(20 − 24]
> 24




PCO2 Continuous† 250.26 0.825 -
PCO2 Dichotomised ≤ 47 281.50 0.742 ≤.0001
> 47
PCO2 3-category ≤ 43 270.76 0.779 0.0002
(43 − 52]
> 52




Cut points were obtained in the derivation sample. AIC and AUC values were
computed in the validation sample
*Corresponding to the DeLong’s test for comparing the AUC of each model with
the continuous option
†AIC and AUC were calculated from the GAM
Furthermore, when the model for the 4-category option
was adjusted, statistically significant differences were
found between the estimated parameters for the (52-65]
and > 65 categories (p < 0.0001). Lastly, the Hosmer-
Lemeshow test assessed the goodness-of-fit of both the 3-
and 4-category options (p > 0.05). Detailed results are
shown in Table 2.
Moreover, when the proposed 4-category option was
applied to other outcomes, such as admission to ward, it
was able to detect differences between categories. When
compared to the average-risk category, the estimates of
the coefficients for the low-, high- and very high-risk cat-
egories were−0.16, 0.67 and 1.49 respectively (p-values of
0.24, < 0.001 and < 0.001 respectively).
Additionally, testing the performance of both variables
in a multivariate logistic regression model, comparison
between the model with RR and PCO2 as continuous
and that with these two variables classified into 3 and 4
categories respectively yielded no statistically significant
Table 2 Results of the adjusted logistic regressionmodels
with the 4–category option for the respiratory rate (RR)
and PCO2 covariates from the IRYSS-COPD Study, showing
estimates of the beta coefficients, their 95% confidence
intervals and the p-values of their significance
Category Estimate 95%CI p-value
RR ≤ 20 -1.76 (-2.37 , -1.16) < 0.0001
RR (20 − 24] -1.22 (-1.86 , -0.58) 0.0002
RR (24 − 30] -0.56 (-1.18 , 0.06) 0.074
RR > 30 - - -
Hosmer-Lemeshow test p-value > 0.05
PCO2 ≤ 43 -3.48 (-4.18 , -2.86) < 0.0001
PCO2 (43 − 52] -2.62 (-3.27 , -2.03) < 0.0001
PCO2 (52 − 65] -1.44 (-1.97 , -0.93) < 0.0001
PCO2 > 65 - - -
Hosmer-Lemeshow test p-value > 0.05
differences in AUCs (AUC=0.827 for the former versus
AUC=0.814 for the latter; p = 0.7021).
Finally, results from the sensitivity analysis for sample
size variation for PCO2 are shown in Figure 4.
Discussion
In clinical practice, decisions need to be made by refer-
ence to clinical parameters, which are usually continuous
measurements. Accurate knowledge of the relationship
between such parameters and the risk of developing a
certain outcome helps identify individuals most at risk.
Considering these parameters as continuous predictors is
preferable from a statistical point of view, since categori-
sation may lead to loss of information and reduction in
power [3]. Nevertheless, in the development of CPRs for
application in clinical practice, it may be preferable for a
certain amount of information to be sacrificed in the inter-
ests of enhanced utility and ease of use in daily clinical
practice.
When the researchers were developing a prediction
model in the context of the IRYSS-COPD Study, several
reasons led them to categorise the continuous clinical
variables that had been collected for study purposes. Not
all the data needed for the study were available in the
clinical records, and even where these were available,
they were not always in a desirable format, appearing, for
instance, as a description of patient status rather than a
numerical value, e.g., in the IRYSS-COPD Study, some
patients’ RR was recorded as “eupneic” or “taquibneic”
instead of being cited as a number on a continuous scale.
Despite the fact that clinicians failed to agree on the cut
points to apply to each code, they did, in contrast, regard
the “eupneic” and “taquibneic” patients as “normal” and
“altered” respectively, which means that, while they would
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Figure 4 Graphical representation of the average-risk category width and location for PCO2 based on sample size.
be able to classify such patients on a categorical scale,
they would nevertheless leave them as missing data on a
continuous scale. The adoption of categorisation of these
parameters that are partially available as continuous vari-
able and partially available as ordinal variable facilitate
reconciliation of information. Moreover, in a study such
as the IRYSS-COPD [16], ED clinical practice prevails
over research requirements. Hence, the data available was
the information routinely recorded at the ED for COPD
patients. In our opinion, the sacrifice of some information
in the subset of data recorded as continuous variable to
avoid information exclusion of the subset of data recorded
as ordinal variable is a worthwhile trade-off. One conse-
quence of this was that, categorisation of variables such
as RR, enabled an average of 38% of values not to be
excluded.
Bearing this in mind, our aim was to furnish a method
of categorisation for clinical parameters selected as pre-
dictors, taking the following three principles into account:
1) categorisation would depend on the outcome of inter-
est and, by extension, on the model selected for analysis;
2) any loss of information as compared to the contin-
uous predictor would be minimal; and 3) the method
would provide clinicians with a convenient and easily
interpretable categorical predictor.
Studying the relationship between the predictor and
the outcome was absolutely necessary in order to
fulfil the first two principles. We decided to start by plot-
ting the relationship graphically. GAM functions were
selected because they are a powerful technique for esti-
mating the relationship between continuous predictor
variables and outcomes [11], with no need for any assump-
tions about this relationship. P-spline smoothers are sug-
gested in the literature as being the most convenient
technique for estimating smooth functions [21]. When
developing the proposed methodology, we considered the
method suggested by Hin et al. (1999) [8] as the first
approach to our designated objective: their proposal con-
sists of dichotomising the predictor variable by using
GAMs, taking the value for which an average risk is
obtained as the cut point. We felt that a specific cut point
could be highly dependent on the sample size or even the
random sample itself, and that an interval, rather than
a single point, might therefore be a wiser choice as an
average-risk category. Although sample size would also
affect the length of any interval, the latter would never-
theless provide more information to clinicians than would
a single point. On the other hand, ensuring a minimum
loss of information vis-à-vis the continuous variable was
one of our stated goals, and so we hypothesised that two
categories were possibly not enough.
Our proposal, motivated in part by the work by Hin
et al (1999) [8], occupies the middle ground between
their approach and the original continuous predictor.
This paper shows that our categorisation proposal does
not lose critical information from the original predictor,
respects the relationship between the original predictor
and the outcome, and offers validated results with bet-
ter predictive ability than does the dichotomous approach.
Moreover, our proposal starts by suggesting a minimum
number of 3 categories, and offering the necessary cut
points to ensure that such a categorisation is a good cate-
gorised approximation to the continuous option. We have
shown that in general, this approach improves Hin et al
proposal (1999) in terms of fitting and prediction. The
proposal includes a method to build an interval around
the average-risk point using the inverse of the 95% confi-
dence interval for the expected response. Although more
complex techniques could provide other alternatives, in
our opinion this is a simple and easy to understand way
that shows the advantages and usefulness of a three cat-
egory approach. In any given case, the need for more
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categories can be evaluated by researchers, depending
upon the relationship between the predictor and the out-
come, sample size and clinical knowledge of the problem.
Moreover, any improvement resulting from the addition
of more categories can be statistically tested. Although
this is an illustrative example, in the application presented
here we selected 4 categories for PCO2 and 3 categories
for RR.
The first limitation of the proposed categorisation lies in
the fact that it depends on the outcome and so its use can-
not be recommended in every situation. This means that
one might obtain different categorisation proposals for
the same predictor, if one were to consider different out-
comes or different modelling approaches. Although this
characteristic of the proposal could be seen as a strength
in the specific modelling situation, it must however be
carefully reviewed when different modelling situations are
being considered. Moreover, the proposed method of cat-
egorisation for one continuous predictor can be applied
with additional (continuous or categorical) covariates in
the model, which means that categorisation can be tai-
lored to the model, including adjustment for several con-
founders. We have previously mentioned that the width
of the average-risk category will depend on sample size,
which is an obvious limitation. Sensitivity analysis showed
that for sample sizes above 200 results were quite stable,
while for size 200 the interval was much wider. In our
opinion, for a moderate sample size as 200 probably there
was not enough data to catch the relationship between the
predictor and the response variable, and so, the average-
risk category became very wide. In a simulation study with
samples of size 200, we obtained that in 90% of them there
were no differences between our proposal and the method
suggested by Hin et al. (1999) [8]. Therefore, in this case
we would recommend to check the performance of the
dichotomised option first, merely for simplicity. Never-
theless, our proposal includes assessing the need for that
third category in each case, and it compares the two ver-
sus the three categories approaches. The third limitation
of our proposal resides in the subjectivity implied in the
selection of extra cut points, in cases where more than
three categories were necessary. We have given an outline
of a way to do this in two different situations; and indeed,
the addition of extra cut points in one of the specific
applications was shown to improve the final result. How-
ever, we have also shown that improvement is progressive,
increasing as more cut points are added, basically because
comparison is made with the continuous predictor. Cut
points are selected on the basis of the predictor/outcome
relationship given by the graphical display, which means
that as more cut points are added, not only will the cat-
egorical and the continuous predictors be more similar,
but the selected categorisation will also be more data-
dependent. Apart from statistical significance, therefore,
an important part of researchers’ work will be to seek a
balance between loss of information and practicality.
In brief, we propose a method for categorising con-
tinuous predictors in clinical prediction models, which
includes both the number of categories and the best cut
points. The proposal has been face-validated by clinicians,
and the proposed categorical predictor has been shown to
perform as successfully as the original continuous predic-
tor when it comes to developing CPRs.
Appendix 1: Splines
In general, the generalized additive model has the follow-
ing structure




where μ = E(Y ) for Y, a response variable with some
exponential family distribution, g is the link function, and
fi are some smooth functions of the covariates Xi for each
i = 1, . . . , p.
The most common alternative for the estimation of the
smooth functions fi are based on splines. Splines are piece-
wise polynomials, being pieces defined by a sequence of
knots ζ1 < ζ2 < . . . ζm, in such a way that pieces join
smoothly at these knots. A spline of degree r can be







γk(x − ζk)r+, (5)
where
(x − ζk)r+ =
{
x − ζk ifx > ζk
0 otherwise
The most popular splines are cubic splines or splines of
degree 3 (r = 3), of the form:
S(x) = α0 + α1x + α2x2 + α3x3 +
m∑
k=1
γk(x − ζk)3+ (6)
Smoothing splines are discussed in detail in Green
and Silverman (1994) [13]. The use of smoothing splines
with as many nodes as observations per GAM compo-
nent, reduces the problem to the GLM with a penalty
parameter of the curvature of the curve, thus imposing
smoothing. Traditionally, smooth functions estimation is
performed at a time, through an iterative algorithm on
each smooth function, keeping the rest of the GAM com-
ponents fixed in the obtained estimation, until the conver-
gence is achieved. The resulting system of equations has
N × p equations, which makes it a computationally diffi-
cult estimation problem (N number of observations and p
number of covariates).
An alternative which allows to adjust all the smooth
functions integrated in the GAM simultaneously is the use
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of regression splines, where the smooth functions are built
as the sum of B-splines [22]. Actually, what it is used is a
base of splines to build the smooth functions, hence the
name B-splines. In general, a B-spline basis of degree r
comprises:
1. (r + 1) piecewise polynomials, each of degree r
2. These (r + 1) piecewise polynomials join at r inner
knots.
3. At the junction point, the derivatives up to r − 1
order are continuous.
4. The B-spline is positive on a domain covered by r + 2
knots and zero otherwise.
5. Except at the frontiers, each B-spline overlaps with
2r neighbour piecewise polynomials.
6. For each value x of X, there are r + 1 non-zero
B-splines.
In this way, a smooth B-spline base is independent of the
response variable. The smooth functions are modelled as
a base of B-splines depending on the following factors: i)
the range of the independent variable X; ii) The number
and location of knots; and iii) the degree of the B-spline.
When using this smoothing approach, for each GAM
component, the smooth function is reduced to a linear
combination of B-splines fi = Biαi, where for each i =
1, . . . , p, Bi is the B-splines matrix of N × m dimension





B1i(x1) · · · Bmi(x1)
...
...
B1i(xN ) · · · Bmi(xN )
⎞
⎟⎠
and αi = (α1i, . . . ,αmi)T is the m-dimensional coefficient
vector, associated to the B-spline basis, also called the B-
splines amplitudes. As an example, in the particular case
in which there is one covariate and a normally distributed





so that α can be estimated as in a GLM model by mini-







where bjk = Bk(xj) is the value of the k-th B-spline
at the point xj. The smoothness of the curve depends
on the number of B-splines, hence, the number of
knots and the value of the amplitudes, and therefore,
the αvector. The advantage of this option is that B-splines
are easy to build, but the main problem now resides in the
optimization of the position and the number of knots.
An intermediate alternative to build the smooth func-
tions, which considers both the smoothing splines and
the regression splines advantages is the use of penalized
splines also known as P-splines and introduced by Eilers
and Marx [15]. P-splines use fewer knots than smoothing
splines and introduce more general roughness penalties
which relaxes the importance of the knot location. The
idea is to start with a B-spline basis, considering more
knots than if we were using regression splines (but not
as many as observations), and subsequently introduce a
penalization in the same way as if we were using smooth-
ing splines. However, in P-splines, the coefficients of the
model are the ones penalized rather than the curvature.
In this way, similar coefficients are obtained for those
nearby, and this provides a computational advantage over
smoothing splines.
The substitution of the term B-spline for the term P-
spline is motivated by the fact that the model fitting
method is modified. The model based on P-splines is
based on setting a reasonable number of knots, adding
a penalty to the differences in coefficients between each
two adjacent knots. Thus the number of knots ensures
flexibility while avoiding the over-estimation and ensuring
smoothness by penalization.
If we consider the same conditions as in (4) the GAM
based on P-splines can be expressed as:
g(μ) = α0 + Bα (9)
where α=
(
α11, . . . ,α1m1 , . . . ,αp1, . . . ,αpmp
)T is the coef-
ficients vector, mi is the number of P-splines, this is,
the number of knots, for the ith covariate, for each i =
1, . . . , p. and B is the N × (1 +∑pi=1mi) regressor matrix
defined as⎛
⎜⎝
B11(x11) · · · B1m1(x11) · · · Bp1(x1p) · · · Bpmp(x1p)
... · · · ... · · · ... · · · ...
B11(xN1) · · · B1m1(xN1) · · · Bp1(xNp) · · · Bpmp(xNp)
⎞
⎟⎠
In general, the estimation method consists on maximiz-
ing the penalized version of the log-likelihood expressed
as:




where the term l(y;α) represents the log-likelihood of the
vector of response variables Y; for each i = 1, . . . , p the
λi ≥ 0 are the smoothing parameters and Pi is a mi × mi
dimension matrix that defines the penalty structure over
the d-dimensional differences between every two adjacent
P-splines coefficients. The estimationmethod is explained
in detail in [23].
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